After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity

Clinical Transplantation

Volumn 22, Issue 2, 2008, Pages 129-135

  Van Besouw, Nicole M ^a   Van De Wetering, Jacqueline ^a   Van Der Mast, Barbara J ^a   De Kuiper, Ronella ^a   Baan, Carla C ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Immune monitoring; T cells; Tapering immunosuppression; Tolerance

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYTOKINE; GAMMA INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY GRAFT REJECTION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TREATMENT WITHDRAWAL;

AZATHIOPRINE; CALCINEURIN; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT VS HOST REACTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; MYCOPHENOLIC ACID; PREDNISONE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 41049091191     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00754.x     Document Type: Article

References (24)

1. Z and MS. Immunosuppression and immune monitoring after renal transplantation. Semin Dial 2005: 18: 511.
2. Abramowicz D, Del Carmen Rial M, Vitko S et al. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study. J Am Soc Nephrol 2005: 16: 2234.
3. Smak Gregoor PJH, de Sevaux RG, Ligtenberg G et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: A randomized, prospective, multicenter study. J Am Soc Nephrol 2002: 13: 1365.
4. Smak Gregoor PJH, van Gelder T, van Besouw NM, van der Mast BJ, IJzermans JN, Weimar W. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Transplantation 2000: 70: 143.
5. van der Mast BJ, Rischen-Vos J, de Kuiper P, Vaessen LMB, van Besouw NM, Weimar W. Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency. Transplantation 2005: 80: 1220.
6. Vanrenterghem Y, Ponticelli C, Morales JM et al. Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 2003: 3: 835.
7. van de Wetering J, van der Mast BJ, de Kuiper P et al. Reduction of immunosuppressive load in renal transplant recipients with a low donor-specific cytotoxic T-lymphocyte precursor frequency is safe. Transplant Proc 2005: 37: 779.
8. van Besouw NM, van der Mast BJ, de Kuiper P et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000: 70: 136.
9. van Besouw NM, Zuijderwijk JM, de Kuiper P, IJzermans JN, Weimar W, van der Mast BJ. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 2005: 79: 1062.
10. Strijbosch LW, Does RJ, Buurman WA. Computer aided design and evaluation of limiting and serial dilution experiments. Int J Biomed Comput 1988: 23: 279.
11. Kirk AD, Mannon RB, Swanson SJ, Hale DA. Strategies for minimizing immunosuppression in kidney transplantation. Transpl Int 2005: 18: 2.
12. Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev 2003: 192: 161.
13. Cohn RG, Mirkovich A, Dunlap B et al. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 1999: 68: 411.
14. Izeradjene K, Revillard JP. Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment. Transplantation 2001: 71: 118.
15. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 2002: 196: 851.
16. + T cell suppressor function. J Immunol 2004: 172: 6519.
17. Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 2005: 201: 723.
18. Baan CC, van der Mast BJ, Klepper M et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 2005: 80: 110.
19. + regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006: 108: 390.
20. Shibutani S, Inoue F, Aramaki O et al. Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. Transplantation 2005: 79: 904.
21. Banerjee D, Dhodapkar MV, Matayeva E, Steinman RM, Dhodapkar K. Expansion of FOXP3 high regulatory T cells by human dendritic cells (DCs) in vitro and after DC injection of cytokine matured DCs in myeloma patients. Blood 2006: 108: 2455.
22. Mehling A, Grabbe S, Voskort M, Schwarz T, Luger TA, Beissert S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol 2000: 165: 2374.
23. Waldmann H, Graca L, Cobbold S, Adams E, Tone M, Tone Y. Regulatory T cells and organ transplantation. Semin Immunol 2004: 16: 119.
24. Velthuis JH, Mol WM, Weimar W, Baan CC. CD4(+) CD25(bright+) regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 2006: 6: 2955.